Back
ZyVersa Therapeutics Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
9
ZVSA
ZyVersa Therapeutics
Last Price:
$0.53
Seasonality Move:
-33.67%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZVSA is experiencing slight buying pressure.
ZyVersa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.6 | Sell |
| 20-day SMA: | 0.67 | Sell |
| 50-day SMA: | 0.75 | Sell |
| 200-day SMA: | 1.63 | Sell |
| 8-day EMA: | 0.6 | Sell |
| 20-day EMA: | 0.66 | Sell |
| 50-day EMA: | 0.78 | Sell |
| 200-day EMA: | 14.13 | Sell |
ZyVersa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 39.63 | Sell |
| Chaikin Money Flow: | 100143 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.56 - 0.86) | Sell |
| Bollinger Bands (100): | (0.72 - 1.3) | Sell |
ZyVersa Therapeutics Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ZyVersa Therapeutics Stock
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.53 while ZVSA 8-day simple moving average is 0.60, which is a Sell signal.
-
The stock price of ZVSA is 0.53 while ZyVersa Therapeutics 20-day SMA is 0.67, which makes it a Sell.
-
ZyVersa Therapeutics 50-day simple moving average is 0.75 while ZVSA share price is 0.53, making it a Sell technically.
-
ZVSA stock price is 0.53 and ZyVersa Therapeutics 200-day simple moving average is 1.63, creating a Sell signal.
ZVSA Technical Analysis vs Fundamental Analysis
Sell
9
ZyVersa Therapeutics (ZVSA)
is a Sell
Is ZyVersa Therapeutics a Buy or a Sell?
-
ZyVersa Therapeutics stock is rated a SellThe current ZyVersa Therapeutics [ZVSA] share price is $0.53. The Score for ZVSA is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
ZyVersa Therapeutics Stock Info
Market Cap:
1.9M
Price in USD:
0.53
Share Volume:
839.1K
ZyVersa Therapeutics 52-Week Range
52-Week High:
6.30
52-Week Low:
0.47
Sell
9
ZyVersa Therapeutics (ZVSA)
is a Sell
ZyVersa Therapeutics Share Price Forecast
-
What is the ZyVersa Therapeutics stock price today?The ZyVersa Therapeutics stock price is 0.53 USD today.
-
Will ZVSA stock go up or go down?ZyVersa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is ZyVersa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ZyVersa Therapeutics is overvalued.
Is ZyVersa Therapeutics Stock a Buy?
-
ZyVersa Therapeutics share price is 0.53 while ZVSA 8-day exponential moving average is 0.60, which is a Sell signal.
-
The stock price of ZVSA is 0.53 while ZyVersa Therapeutics 20-day EMA is 0.66, which makes it a Sell.
-
ZyVersa Therapeutics 50-day exponential moving average is 0.78 while ZVSA share price is 0.53, making it a Sell technically.
-
ZVSA stock price is 0.53 and ZyVersa Therapeutics 200-day simple moving average is 14.13, creating a Sell signal.
Fundamental Analysis of ZyVersa Therapeutics
Is ZyVersa Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $1.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $11.20 per share, and a decrease next year of $0.00 per share.
Technical Analysis of ZyVersa Therapeutics
Should I short ZyVersa Therapeutics stock?
-
ZVSA Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting ZyVersa Therapeutics is a Sell
-
ZyVersa Therapeutics Relative Strength Index (RSI) is 39.63, which suggest ZyVersa Therapeutics is oversold
-
The Bollinger Bands (25) for ZyVersa Therapeutics is (0.56 - 0.86), which suggest ZyVersa Therapeutics is a Sell
-
The Bollinger Bands (100) for ZyVersa Therapeutics is (0.72 - 1.3), which suggest ZyVersa Therapeutics is a Sell
* ZyVersa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.